Live Breaking News & Updates on Renovorx Inc

Stay updated with breaking news from Renovorx inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Contrasting Verrica Pharmaceuticals (NASDAQ:VRCA) and RenovoRx (NASDAQ:RNXT)

Verrica Pharmaceuticals (NASDAQ:VRCA – Get Free Report) and RenovoRx (NASDAQ:RNXT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, analyst recommendations and profitability. Earnings & Valuation This table compares Verrica Pharmaceuticals […] ....

West Chester , United States , Los Altos , Torii Pharmaceutical Co Ltd , Verrica Pharmaceuticals Inc , Verrica Pharmaceuticals , Renovorx Inc , News Ratings For Verrica Pharmaceuticals Daily , Get Free Report , Given Renovorx , Pharmaceuticals Inc , Lytix Biopharma , Imugene Limited , Verrica Pharmaceuticals Daily ,

RenovoRx CEO Issues Update Letter to Shareholders

RenovoRx CEO Issues Update Letter to Shareholders
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Paulam Novelli , David Sperling , Shaunr Bagai , Ronaldb Kocak , Khashayar Farsad , Shaun Bagai , Society Of Interventional Radiology Annual Scientific Meeting , Company Nasdaq , Department Of Interventional Radiology At Oregon Health , Securities Exchange , University Of Pittsburgh Hillman Cancer Center , Renovorx Inc , Data Monitoring Committee , Science University , Exchange Commission , Chief Executive Officer , Fellow Renovorx Shareholders , Locally Advanced Pancreatic Cancer , Trans Arterial Micro Perfusion , Scientific Advisory Board , Leesa Gentry , Chief Clinical Officer , Principal Accounting , Vascular Interventional ,

Publication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx's TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment Delivery

Data shows that the Trans-Arterial Micro-Perfusion platform increases intra-arterial pressure, improving drug delivery with 100-fold increase local tissue concentration of the therapy

TAMP offers. ....

United States , Khashayar Farsad , Paulam Novelli , Renovorx Inc , University Of Pittsburgh Hillman Cancer Center , American Cancer Society Facts Figures , Department Of Interventional Radiology At Oregon Health , Science University , Data Monitoring Committee , Exchange Commission , Company Nasdaq , Securities Exchange , Trans Arterial Micro Perfusion , Vascular Interventional Radiology , Interventional Radiology , Oregon Health , Pittsburgh Hillman Cancer Center , Chief Medical Officer , R Pac Clinical , Locally Advanced Pancreatic Cancer , Overall Survival , American Cancer Society , Cancer Facts , Drug Evaluation , Securities Act , Securities Exchange Act ,

RenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital Virtual Conference on May 9, 2024

RenovoRx, Inc. , a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced that Shaun R. Bagai, Chief. ....

Shaun Bagai , Shaunr Bagai , Strategic Communications , Renovorx Inc , Company Nasdaq , Securities Exchange , Exchange Commission , Chief Executive Officer , Aegis Capital Virtual Conference , Trans Arterial Micro Perfusion , Capital Virtual Conference , Aegis Capital , Drug Evaluation , Securities Act , Securities Exchange Act , R Pac Phase ,

RenovoRx Regains Compliance with Nasdaq Stockholders' Equity Requirement

RenovoRx, Inc. , a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced that, in light of its recent. ....

Shaun Bagai , Nasdaq Stock Market , Renovorx Inc , Nasdaq Hearings Panel , Company Nasdaq , Securities Exchange , Exchange Commission , Nasdaq Listing Rule , Chief Executive Officer , Trans Arterial Micro Perfusion , Drug Evaluation , Securities Act , Securities Exchange Act , R Pac Phase ,